Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study

Autor: Cuneo, A, Follows, G, Rigolin, GM, Piciocchi, A, Tedeschi, A, Trentin, L, Perez, AM, Coscia, M, Laurenti, L, Musuraca, G, Farina, L, Delgado, AR, Orlandi, EM, Galieni, P, Mauro, FR, Visco, C, Amendola, A, Billio, A, Marasca, R, Chiarenza, A, Meneghini, V, Ilariucci, F, Marchetti, M, Molica, S, Re, F, Gaidano, G, Gonzalez, M, Forconi, F, Ciolli, S, Cortelezzi, A, Montillo, M, Smolej, L, Schuh, A, Eyre, TA, Kennedy, B, Bowles, KM, Vignetti, M, de la Seam, J, Moreno, C, Foa, R, Ghia, P, GIMEMA, European Res Initiative CLL ERIC, UK CLL Forum

Publikováno v: HAEMATOLOGICA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

We performed an observational study on the efficacy of ben-damustine and rituximab (BR) as first salvage regimen in chronic lymphocytic leukemia (CLL). In an intention-to-treat analysis including 237 patients, the median progression-free survival (PF

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3da97517ae196f6a9a9be16c79c4c7bd
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3485

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.

Autor: Cuneo A; Hematology, Department of Medical Sciences, St. Anna University Hospital, Ferrara, Italy cut@unife.it., Follows G; UK CLL Forum, Cambridge University Hospitals NHS Foundation Trust, UK., Rigolin GM; Hematology, Department of Medical Sciences, St. Anna University Hospital, Ferrara, Italy., Piciocchi A; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy., Tedeschi A; Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Trentin L; Hematology and Clinical Immunology, Department of Medicine, University of Padua, Italy., Perez AM; Hospital Costa del Sol, Marbella, Málaga, Spain., Coscia M; Hematology Unit, Città della Salute e della Scienza, University of Turin, Italy., Laurenti L; Hematology, Università Cattolica del Sacro Cuore, Policlinico A. Gemelli, Rome, Italy., Musuraca G; Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Farina L; Hematology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy., Delgado AR; Department of Hematology, Hospital Clinic, Institut Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Orlandi EM; Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Galieni P; Hematology and Cellular Therapy, 'Ospedale C. e G. Mazzoni', Ascoli Piceno, Italy., Mauro FR; Hematology, Department of Biomedical Sciences and Hematology, 'Sapienza' University, Rome, Italy., Visco C; Hematology, San Bortolo Hospital, Vicenza, Italy., Amendola A; Hematology, San Carlo Hospital, Potenza, Italy., Billio A; Hematology and Transplant Unit, San Maurizio Hospital, Azienda Sanitaria dell'Alto Adige, Bolzano, Italy., Marasca R; Hematology Unit, University Hospital, Modena, Italy., Chiarenza A; Hematology Unit, Azienda Universitaria Ospedaliera Policlinico Vittorio Emanuele, Catania, Italy., Meneghini V; Hematology, Department of Cell Therapy and Hematology, University Hospital, Verona, Italy., Ilariucci F; Hematology Unit, Arcispedale S. Maria Nuova, Reggio Emilia, Italy., Marchetti M; Oncology Unit, Cardinal Massaia Hospital, Asti, Italy., Molica S; Hematology Unit, A. Pugliese Hospital, Azienda Ospedaliera Pugliese Ciaccio, Catanzaro, Italy., Re F; Hematology, University Hospital, Parma, Italy., Gaidano G; Hematology, DIMECS e Dipartimento Oncologico, Università del Piemonte Orientale Amedeo Avogadro, Novara, Italy., Gonzalez M; Hematology, University Hospital-IBSAL and CIBERONC, Salamanca, Spain., Forconi F; Haematology Department, University Hospital National Health Service Trust, Southampton, UK., Ciolli S; Hematology Unit, Careggi Hospital, Florence, Italy., Cortelezzi A; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Italy., Montillo M; Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Smolej L; Department of Hematology, University Hospital, Hradec Kralove, Czech Republic., Schuh A; UK CLL Forum, Oxford University Hospitals NHS Foundation Trust, UK., Eyre TA; Oxford University Hospitals NHS Foundation Trust, UK., Kennedy B; University Hospitals of Leicester NHS Trust, UK., Bowles KM; Norwich Medical School, UK., Vignetti M; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy., de la Serna J; Hematology Unit, Hospital Universitario 12 de Octubre, Madrid, Spain., Moreno C; Hospital de la Santa Creu i Sant Pau, Barcellona, Spain., Foà R; Hematology, Department of Biomedical Sciences and Hematology, 'Sapienza' University, Rome, Italy., Ghia P; Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy.

Publikováno v: Haematologica [Haematologica] 2018 Jul; Vol. 103 (7), pp. 1209-1217. Date of Electronic Publication: 2018 Apr 19.